Question 1

Does Polar Capital Holdings own PCVX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Polar Capital Holdings holds 1,185,943 shares of PCVX (Vaxcyte), worth $68.9M.

Question 2

How many shares of PCVX does Polar Capital Holdings own?

Accepted Answer

As of its Q2 2026 13F, Polar Capital Holdings holds 1,185,943 shares of PCVX (Vaxcyte).

Question 3

What is Polar Capital Holdings' PCVX position worth?

Accepted Answer

As of its Q2 2026 13F, Polar Capital Holdings' PCVX position is worth $68.9M.

Question 4

Is Polar Capital Holdings buying or selling PCVX?

Accepted Answer

In Q2 2026, Polar Capital Holdings reduced its PCVX position by 239,845 shares (-16.8%).

Question 5

When did Polar Capital Holdings first buy PCVX?

Accepted Answer

Polar Capital Holdings first reported PCVX in its Q3 2024 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1.2M	-16.8%	$68.9M	0.2%	$58.13	0
2026-Q1	Decreased	1.4M	-14.8%	$82.9M	0.3%	$59.82	0
2025-Q4	Increased	1.7M	+302.6%	$77.2M	0.3%	$45.41	57
2025-Q3	Decreased	415,530	-49.7%	$15M	0.1%	$34.65	0
2025-Q2	Decreased	825,795	-23.7%	$26.8M	0.1%	$32.58	0
2025-Q1	Increased	1.1M	+11.2%	$40.9M	0.2%	$69.46	39
2024-Q4	Decreased	973,645	-2.2%	$79.7M	0.4%	$81.99	0
2024-Q3	New	995,779	-	$113.8M	0.5%	$113.14	59

PCVX8 quarters

PCVX
8 quarters